FDA recall, , Moderate risk
American National Red Cross Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced were not tested for pH or platelet count.
The American National Red Cross began this recall on May 15, 2026. FDA posted it on Nov 4, 2026, the day the recall ended.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross, based in Cleveland, Ohio, voluntarily recalled Apheresis Platelets, PAS, Leukocytes Reduced because the products were not tested for pH or platelet count. The recall was initiated by the firm on May 15, 2026, and was added to the FDA's Enforcement Report on November 4, 2026. Customers were notified by telephone.
What to do
Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.
What was recalled
Hospitals, clinics and blood banks match these details against their records.
Apheresis Platelets, PAS, Leukocytes Reduced
- Unit number
- W18422683340100Y
Recall details
- Posted by FDA
- Recall began
- Status
- Ended Nov 4, 2026
- Weekly archive
- Listed the week of Nov 2, 2026
- Distributed to
- Recalled by
- The American National Red CrossCleveland, Ohio
- Hazard
- Quality testing problem
- Risk
Moderate risk
Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100028
- Recall number
- B-0036-2027
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- Telephone
All recalls from The American National Red Cross
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
The American National Red Cross began the recall
FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it
Added to Recall Canary